stockportfolio.pro
Ligand Pharmaceuticals Incorporated Net Income 2009–2025
Ligand Pharmaceuticals Incorporated (LGND) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $124.45M | 46.4% | +3186.6% |
| FY 2024 | $-4.03M | -2.4% | -107.7% |
| FY 2023 | $52.15M | 39.7% | +256.3% |
| FY 2022 | $-33.36M | -17.0% | -158.4% |
| FY 2021 | $57.14M | 23.7% | +2014.2% |
| FY 2020 | $-2.98M | -1.8% | -100.5% |
| FY 2019 | $629.30M | 523.2% | +339.1% |
| FY 2018 | $143.32M | 57.0% | +1041.5% |
| FY 2017 | $12.56M | 8.9% | +867.5% |
| FY 2016 | $-1.64M | -1.5% | -100.7% |
| FY 2015 | $229.82M | 319.6% | +1811.4% |
| FY 2014 | $12.02M | 18.6% | +5.3% |
| FY 2013 | $11.42M | 23.3% | +2267.0% |
| FY 2012 | $-527,000 | -1.7% | -105.4% |
| FY 2011 | $9.71M | 32.3% | +193.7% |
| FY 2010 | $-10.37M | -44.1% | -432.5% |
| FY 2009 | $-1.95M | -5.0% | — |
Source: Ligand Pharmaceuticals Incorporated SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Ligand Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeLigand Pharmaceuticals Incorporated — frequently asked questions
What is Ligand Pharmaceuticals Incorporated's net income?
Ligand Pharmaceuticals Incorporated (LGND) reported net income of $124.45M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Ligand Pharmaceuticals Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.